Atherogenic Index of Plasma (AIP): The Most Accurate Indicator of Overweight and Obesity Among Lipid Indices in Type 2 Diabetes—Findings From a Cross‐Sectional Study

ABSTRACT Background This study aimed to evaluate the relationships of conventional and calculated lipid indices with obesity or overweight in patients with type 2 diabetes (T2D). Methods In this cross‐sectional study, all participants were categorised into three groups: normal weight (18 ≤ BMI < ...

Full description

Saved in:
Bibliographic Details
Main Authors: Sahar Karimpour Reyhan, Amirhossein Yadegar, Sahar Samimi, Pooria Nakhaei, Alireza Esteghamati, Manouchehr Nakhjavani, Soheil Karimpour Reihan, Soghra Rabizadeh
Format: Article
Language:English
Published: Wiley 2024-11-01
Series:Endocrinology, Diabetes & Metabolism
Subjects:
Online Access:https://doi.org/10.1002/edm2.70007
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850128959237259264
author Sahar Karimpour Reyhan
Amirhossein Yadegar
Sahar Samimi
Pooria Nakhaei
Alireza Esteghamati
Manouchehr Nakhjavani
Soheil Karimpour Reihan
Soghra Rabizadeh
author_facet Sahar Karimpour Reyhan
Amirhossein Yadegar
Sahar Samimi
Pooria Nakhaei
Alireza Esteghamati
Manouchehr Nakhjavani
Soheil Karimpour Reihan
Soghra Rabizadeh
author_sort Sahar Karimpour Reyhan
collection DOAJ
description ABSTRACT Background This study aimed to evaluate the relationships of conventional and calculated lipid indices with obesity or overweight in patients with type 2 diabetes (T2D). Methods In this cross‐sectional study, all participants were categorised into three groups: normal weight (18 ≤ BMI < 25), overweight (25 ≤ BMI < 30) and obese (BMI ≥ 30). Conventional lipid indices, including triglyceride (TG), total cholesterol, LDL‐C and HDL‐C, were measured. Lipid indices, including the atherogenic index of plasma (AIP), non‐HDL‐C, TC/HDL‐C, LDL‐C/HDL‐C, non‐HLD‐C/HDL‐C (atherogenic index, AI) and lipoprotein combine index (LCI), were calculated. The associations of these lipid indices with obesity and overweight status were evaluated using univariate and multivariate multinomial logistic regression analyses. Results In this study, 2661 patients with T2D, including 651 patients with normal weight, 1144 with overweight, and 866 with obesity, were recruited. According to a multinomial logistic regression analysis after adjustment for multiple confounders, the odds ratio (OR) was greater for the AIP than for other conventional and calculated lipid indices in overweight and obese patients with T2D. The AIP had a significant relationship with overweight, with an OR of 4.79 (95% CI: 1.65–13.85), and it had a significant relationship with obesity, with an OR of 13.64 (95% CI: 3.96–47.04). According to the ROC curve, with a cut‐off value of 0.68, AIP could predict obesity with 82% sensitivity and 55% specificity (AUC = 0.770, 95% CI: 0.729–0.812, p < 0.001). Conclusion Compared with other conventional and calculated lipid markers, the AIP is most strongly associated with obesity and overweight in patients with T2D.
format Article
id doaj-art-d0345b729eb84444a42323d9577e97b0
institution OA Journals
issn 2398-9238
language English
publishDate 2024-11-01
publisher Wiley
record_format Article
series Endocrinology, Diabetes & Metabolism
spelling doaj-art-d0345b729eb84444a42323d9577e97b02025-08-20T02:33:08ZengWileyEndocrinology, Diabetes & Metabolism2398-92382024-11-0176n/an/a10.1002/edm2.70007Atherogenic Index of Plasma (AIP): The Most Accurate Indicator of Overweight and Obesity Among Lipid Indices in Type 2 Diabetes—Findings From a Cross‐Sectional StudySahar Karimpour Reyhan0Amirhossein Yadegar1Sahar Samimi2Pooria Nakhaei3Alireza Esteghamati4Manouchehr Nakhjavani5Soheil Karimpour Reihan6Soghra Rabizadeh7Endocrinology and Metabolism Research Center (EMRC), Vali‐Asr Hospital Tehran University of Medical Sciences Tehran IranEndocrinology and Metabolism Research Center (EMRC), Vali‐Asr Hospital Tehran University of Medical Sciences Tehran IranEndocrinology and Metabolism Research Center (EMRC), Vali‐Asr Hospital Tehran University of Medical Sciences Tehran IranEndocrinology and Metabolism Research Center (EMRC), Vali‐Asr Hospital Tehran University of Medical Sciences Tehran IranEndocrinology and Metabolism Research Center (EMRC), Vali‐Asr Hospital Tehran University of Medical Sciences Tehran IranEndocrinology and Metabolism Research Center (EMRC), Vali‐Asr Hospital Tehran University of Medical Sciences Tehran IranMechanical Engineering School University of Tehran Tehran IranEndocrinology and Metabolism Research Center (EMRC), Vali‐Asr Hospital Tehran University of Medical Sciences Tehran IranABSTRACT Background This study aimed to evaluate the relationships of conventional and calculated lipid indices with obesity or overweight in patients with type 2 diabetes (T2D). Methods In this cross‐sectional study, all participants were categorised into three groups: normal weight (18 ≤ BMI < 25), overweight (25 ≤ BMI < 30) and obese (BMI ≥ 30). Conventional lipid indices, including triglyceride (TG), total cholesterol, LDL‐C and HDL‐C, were measured. Lipid indices, including the atherogenic index of plasma (AIP), non‐HDL‐C, TC/HDL‐C, LDL‐C/HDL‐C, non‐HLD‐C/HDL‐C (atherogenic index, AI) and lipoprotein combine index (LCI), were calculated. The associations of these lipid indices with obesity and overweight status were evaluated using univariate and multivariate multinomial logistic regression analyses. Results In this study, 2661 patients with T2D, including 651 patients with normal weight, 1144 with overweight, and 866 with obesity, were recruited. According to a multinomial logistic regression analysis after adjustment for multiple confounders, the odds ratio (OR) was greater for the AIP than for other conventional and calculated lipid indices in overweight and obese patients with T2D. The AIP had a significant relationship with overweight, with an OR of 4.79 (95% CI: 1.65–13.85), and it had a significant relationship with obesity, with an OR of 13.64 (95% CI: 3.96–47.04). According to the ROC curve, with a cut‐off value of 0.68, AIP could predict obesity with 82% sensitivity and 55% specificity (AUC = 0.770, 95% CI: 0.729–0.812, p < 0.001). Conclusion Compared with other conventional and calculated lipid markers, the AIP is most strongly associated with obesity and overweight in patients with T2D.https://doi.org/10.1002/edm2.70007atherogenic index of plasmadiabeteslipid indicesobesityoverweight
spellingShingle Sahar Karimpour Reyhan
Amirhossein Yadegar
Sahar Samimi
Pooria Nakhaei
Alireza Esteghamati
Manouchehr Nakhjavani
Soheil Karimpour Reihan
Soghra Rabizadeh
Atherogenic Index of Plasma (AIP): The Most Accurate Indicator of Overweight and Obesity Among Lipid Indices in Type 2 Diabetes—Findings From a Cross‐Sectional Study
Endocrinology, Diabetes & Metabolism
atherogenic index of plasma
diabetes
lipid indices
obesity
overweight
title Atherogenic Index of Plasma (AIP): The Most Accurate Indicator of Overweight and Obesity Among Lipid Indices in Type 2 Diabetes—Findings From a Cross‐Sectional Study
title_full Atherogenic Index of Plasma (AIP): The Most Accurate Indicator of Overweight and Obesity Among Lipid Indices in Type 2 Diabetes—Findings From a Cross‐Sectional Study
title_fullStr Atherogenic Index of Plasma (AIP): The Most Accurate Indicator of Overweight and Obesity Among Lipid Indices in Type 2 Diabetes—Findings From a Cross‐Sectional Study
title_full_unstemmed Atherogenic Index of Plasma (AIP): The Most Accurate Indicator of Overweight and Obesity Among Lipid Indices in Type 2 Diabetes—Findings From a Cross‐Sectional Study
title_short Atherogenic Index of Plasma (AIP): The Most Accurate Indicator of Overweight and Obesity Among Lipid Indices in Type 2 Diabetes—Findings From a Cross‐Sectional Study
title_sort atherogenic index of plasma aip the most accurate indicator of overweight and obesity among lipid indices in type 2 diabetes findings from a cross sectional study
topic atherogenic index of plasma
diabetes
lipid indices
obesity
overweight
url https://doi.org/10.1002/edm2.70007
work_keys_str_mv AT saharkarimpourreyhan atherogenicindexofplasmaaipthemostaccurateindicatorofoverweightandobesityamonglipidindicesintype2diabetesfindingsfromacrosssectionalstudy
AT amirhosseinyadegar atherogenicindexofplasmaaipthemostaccurateindicatorofoverweightandobesityamonglipidindicesintype2diabetesfindingsfromacrosssectionalstudy
AT saharsamimi atherogenicindexofplasmaaipthemostaccurateindicatorofoverweightandobesityamonglipidindicesintype2diabetesfindingsfromacrosssectionalstudy
AT poorianakhaei atherogenicindexofplasmaaipthemostaccurateindicatorofoverweightandobesityamonglipidindicesintype2diabetesfindingsfromacrosssectionalstudy
AT alirezaesteghamati atherogenicindexofplasmaaipthemostaccurateindicatorofoverweightandobesityamonglipidindicesintype2diabetesfindingsfromacrosssectionalstudy
AT manouchehrnakhjavani atherogenicindexofplasmaaipthemostaccurateindicatorofoverweightandobesityamonglipidindicesintype2diabetesfindingsfromacrosssectionalstudy
AT soheilkarimpourreihan atherogenicindexofplasmaaipthemostaccurateindicatorofoverweightandobesityamonglipidindicesintype2diabetesfindingsfromacrosssectionalstudy
AT soghrarabizadeh atherogenicindexofplasmaaipthemostaccurateindicatorofoverweightandobesityamonglipidindicesintype2diabetesfindingsfromacrosssectionalstudy